Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Binu John, MD, MPH is a staff physician in the Department of Gastroenterology and Hepatology at the Cleveland Clinic and is an assistant professor at the Cleveland Clinic Lerner College of Medicine. He is board certified in Internal Medicine, Gastroenterology and Transplant Hepatology. His areas of clinical interest include all liver diseases including hepatocellular carcinoma, hepatic sarcoidosis and portal hypertension. Areas of research include outcomes of portal vein thrombosis in cirrhosis, sarcoidosis of the liver and the role of genetic polymorphisms in liver disease. His research is published in multiple medical journals and has been presented at national meetings.
Dr. John has an active interest in resident and fellow education and is an activity director of the Cleveland Clinic GI board review course. He is a member of the American Association of Study of Liver Diseases (AASLD), the American College of Gastroenterology (ACG) and the American Gastroenterological Association (AGA), has served on the journal publications committee of the AASLD. He currently serves on the clinical research as well as the publication committees of the ACG. Dr John sees all new and established patients at the Cleveland Clinic Main Campus and does one day of endoscopic procedures at the Independence family health center.
Liver disease, liver transplantation, cirrhosis, hepatitis B, hepatitis C, nonalcoholic fatty liver disease, portal hypertension, diagnostic and therapeutic EGD (upper endoscopy) and colonoscopy
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 11/18/2014, Dr. John has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.